Symbol="EDSA"
AssetType="Common Stock"
Name="Edesa Biotech Inc"
Description="Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada."
CIK="1540159"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="332 EAST SCOTT STREET, PORT HUENEME, CA, US"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="16986900"
EBITDA="-13319690"
PERatio="None"
PEGRatio="None"
BookValue="0.449"
DividendPerShare="0"
DividendYield="0"
EPS="-0.62"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.54"
ReturnOnEquityTTM="-1.02"
RevenueTTM="500"
GrossProfitTTM="311200"
DilutedEPSTTM="-0.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.999"
AnalystTargetPrice="11.67"
TrailingPE="-"
ForwardPE="0.172"
PriceToSalesRatioTTM="120477.93"
PriceToBookRatio="1.422"
EVToRevenue="128525.38"
EVToEBITDA="-0.223"
Beta="0.747"
num_52WeekHigh="2.81"
num_52WeekLow="0.76"
num_50DayMovingAverage="0.865"
num_200DayMovingAverage="1.144"
SharesOutstanding="20587700"
DividendDate="2019-06-10"
ExDividendDate="None"
symbol="EDSA"
open="0.83"
high="0.85"
low="0.81"
price="0.83"
volume="49567.00"
latest_trading_day="2023-07-21"
previous_close="0.83"
change="-0.00"
change_percent="-0.2900%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="73883"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.95"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="94"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_negative_thumbnail_id_2="172"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="670"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_positive_thumbnail_id_2="614"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0094.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
